Cantor Fitzgerald's new Buy rating on MDRNA, Inc. (Nasdaq: MRNA) is giving that stock a nice ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE